These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 8538031
1. [Multiple endocrine neoplasia type 2A, type 2B and familial medullary thyroid carcinoma syndrome]. Obara T, Yamashita T, Kanbe M, Ito Y, Egawa S, Yamaguchi K. Nihon Rinsho; 1995 Nov; 53(11):2708-15. PubMed ID: 8538031 [Abstract] [Full Text] [Related]
2. [Neural crest and multiple endocrinopathies]. Pasini A, Michiels FM, Chappuis-Flament S, Geneste O, Rossel M, Fournier L, Feunteun J, Lenoir G, Schuffenecker I, Billaud M. C R Seances Soc Biol Fil; 1996 Nov; 190(5-6):557-67. PubMed ID: 9074721 [Abstract] [Full Text] [Related]
3. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes. Skinner MA, Wells SA. Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335 [Abstract] [Full Text] [Related]
4. RET mutations in exons 13 and 14 of FMTC patients. Bolino A, Schuffenecker I, Luo Y, Seri M, Silengo M, Tocco T, Chabrier G, Houdent C, Murat A, Schlumberger M. Oncogene; 1995 Jun 15; 10(12):2415-9. PubMed ID: 7784092 [Abstract] [Full Text] [Related]
5. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan. Kameyama K, Okinaga H, Takami H. Biomed Pharmacother; 2004 Jun 15; 58(6-7):345-7. PubMed ID: 15271413 [Abstract] [Full Text] [Related]
6. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas. Komminoth P. Verh Dtsch Ges Pathol; 1995 Jun 15; 79():L-LV. PubMed ID: 8600671 [Abstract] [Full Text] [Related]
7. [The RET gene in multiple endocrine neoplasia type 2 (MEN 2)]. Ito T, Shirahama S, Ogura K, Yamamoto S, Takami H. Nihon Rinsho; 2004 May 15; 62(5):883-8. PubMed ID: 15148813 [Abstract] [Full Text] [Related]
15. Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients. Fernández RM, Navarro E, Antiñolo G, Ruiz-Ferrer M, Borrego S. Int J Mol Med; 2006 Apr 15; 17(4):575-81. PubMed ID: 16525712 [Abstract] [Full Text] [Related]
16. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers]. Sansó G, Domené HM, Iorcansky S, Barontini M. Medicina (B Aires); 1998 Apr 15; 58(2):179-84. PubMed ID: 9706252 [Abstract] [Full Text] [Related]